{"url_path":"/sec/rlyb/8-k/2026-06-01/item-7-01","section_key":"item-7-01","section_title":"Item 7.01 Other Events.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-01","source_url":"https://www.sec.gov/Archives/edgar/data/1739410/0001193125-26-249790-index.html","accession_number":"0001193125-26-249790","cik":"0001739410","ticker":"RLYB","issuer_name":"Rallybio Corp","edgar_url":"https://www.sec.gov/Archives/edgar/data/1739410/0001193125-26-249790-index.html","primary_entity_key":"0001739410","primary_entity_name":"Rallybio Corp"},"word_count":176,"has_tables":true,"body_markdown":"Item 7.01.\n\nOther Events.\n\nPress Release\n\nOn June 1, 2026, Rallybio and Avenzo issued a joint press release announcing the execution of the Merger Agreement. The press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and incorporated herein by reference, except that the information contained on the websites referenced in the press release is not incorporated herein by reference.\n\nInvestor Presentation and Conference Call Script\n\nOn June 1, 2026, representatives of Rallybio and Avenzo will hold a conference call to investors, which investor presentation and conference call script are furnished as Exhibits 99.2 and 99.3 hereto, respectively, and incorporated herein by reference.\n\nThe information contained in this Item 7.01, including 99.1, 99.2 and 99.3, is deemed to have been furnished and shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, and is not incorporated by reference into any filing under the Securities Act or the Exchange Act."}